Federica Fogacci on Further Strengthening Collaboration Within the Lp(a)CCELERATE Study
Federica Fogacci, Young Fellow at European Atherosclerosis Society, shared on LinkedIn:
”On 17 November, I had the pleasure of taking part in the EAS Lipoprotein(a) Workshop, organized by the European Atherosclerosis Society with the support of Novartis and Fondazione SISA.
It was a highly stimulating opportunity to share experiences on the role of Lp(a) in cardiovascular risk and to further strengthen collaboration within the Lp(a)CCELERATE study.
I left the meeting with clearer ideas, fresh perspectives and – above all – the feeling of being part of a community of colleagues genuinely committed to improving CvPrev
Many thanks to the organizers and to all participants for their questions, insights and openness in building the next steps of this journey together.”
Stay updated with Hemostasis Today.
-
Mar 2, 2026, 17:22Hematologists and Oncologists Recognize Their Role in Specialized VA Care Despite Ongoing Knowledge Gaps – JTH
-
Mar 2, 2026, 17:04Fernando Corrales-Medina: An Evidence-Based Platform Promoting Early Recognition and Evaluation of VWD
-
Mar 2, 2026, 16:56Mbunya S. Misiani: Changing the Narrative on Bleeding Disorders Across Africa
-
Mar 2, 2026, 16:51Ofoke Chiamaka: Rehabilitation Is Not Just Muscle Training, It Is Brain Retraining
-
Mar 2, 2026, 16:41Paul Bolaji: Beyond Acute Stroke Care – Independent Integrated Living After Stroke
-
Mar 2, 2026, 16:37Gianluca Franceschini: Precision Medicine Is Only Truly Effective If It Is Inclusive
-
Mar 2, 2026, 16:34Maha Othman: Calling a Guest Editor for Current Opinion in Hematology
-
Mar 2, 2026, 16:30Tareq Abadl: Erythropoiesis – The Cellular Engineering Behind Oxygen Delivery
-
Mar 2, 2026, 16:28Tagreed Alkaltham: Blood Management in Times of Crisis